drugset

drugset / Trial / NCT01600365

Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

NCT01600365 ↗

Phase 3 Unknown 22 enrolled Adapt Produtos Oftalmológicos Ltda.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to study the use of ganciclovir gel 0.3% for treatment of conjunctivitis caused by adenovirus.

Timeline

Start: 2012-05
Primary completion: 2012-06
Completion: 2012-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Ganciclovir	Small molecule	0.3 %	Topical

Indications